Skip to main content

Utah at AAN 2019


The American Academy of Neurology will hold their AAN Annual Meeting in Philadelphia, Pennsylvania, from May 4–10, 2019. Check out what Utah faculty will be doing there.

Scientific Platforms

Monday, May 6

Time Topic Presenter
3:30 p.m.–5:30 p.m. (presenting 3:52 p.m.) S23.003 Genetic Prevalence of Myotonic Dystrophy Type I N. Johnson, C. Imbrugia, D. Dunn, B. Duvall, R. Butterfield, M. Feldkamp, R. Weiss

Thursday, May 9

Time Topic Presenter
1:00 p.m.–3:00 p.m.
(Presenting 2:17 PM)
S49.008 Distribution and Predictors of Disease Severity in Pediatric Multiple Sclerosis J. Santoro, M. Waltz, T. Casper, T. Chitnis, G. Aaen, A. Belman, L. Benson, M. Candee, M. Gorman, M. Goyal, J. Graves, B. Greenberg, Y. Harris, I. Kahn, L. Krupp, T. Lotze, S. Mar, M. Moodley, J. Ness, M. Rensel, M. Rodriguez, J. Rose, J. Rubin, T. Schreiner, J. Tillema, A. Waldman, E. Waubant, B. Weinstock-Guttman

Experiential Learning Areas

Saturday, May 4

Time Topic Presenter
9:00 a.m.–9:30 a.m. What Should Applicants Look for in a Program? A. de Havenon, P. Hannon

Sunday, May 5

Time Topic Presenter
8:30 a.m.–9:00 a.m. Neuroscience Course Director Conversation P. Hannon

Scientific Posters

Sunday, May 5

Time Topic Presenter
11:30 a.m.–6:30 p.m. P1.2-027 Adult Acute Hemorrhagic Leukoencephalitis: Role of Susceptibility-Weighted Imaging in Diagnosis and Importance of Aggressive Early Immunotherapy D. Sugar, J. Galli, S. Clardy, J. Greenlee
11:30 a.m.–6:30 p.m. P1.2-035 Movement Disorders Associated with Systemic Autoimmunity: A Case Series J. McDonald, P. Moretti, S. Clardy
11:30 a.m.–6:30 p.m. P1.2-041 Neurologic Involvement in Seronegative Sjögren’s Syndrome with Positive Lip Biopsy: A Single Center Experience K. Wong, J. Galli, R. Bacharach, J. Klein, L. Esquibel, L. Pace, D. Leibiedz-Ozrobina, J. Rose, B. Trump, C. Hull, J. Greenlee, S. Clardy
11:30 a.m.–6:30 p.m. P1.2-044 Atypical Epilepsy in Common Variable Immunodeficiency: A Single Institution Case Series J. Galli, J. Kresser, J. Klein, A. Gundlapalli, J. Graff-Radford, J. Greenlee, S. Clardy
11:30 a.m.–6:30 p.m. P1.2-046 Neurosarcoidosis: Longitudinal Experience in a Single-Center, Academic Health Care System J. Lord, R. Bacharach, J. Galli, J. Kresser, J. Klein, L. DeWitt, M. Paz Soldan, J. Rose, J. Greenlee, S. Clardy
11:30 a.m.–6:30 p.m. P1.2-056 Diagnosis and Management of Pachymeningitis D. Wood, R. Bacharach, C. Guo, L. Ryerson, M. Bradshaw, B. Mobley, Y. Wang, J. Gelfand, E. Flanagan, A. Aksamit, S. Clardy, S. Pawate, I. Kister
11:30 a.m.–6:30 p.m. P1.6-059 Phase I Study of Intrathecal Administration of AVXS-101 Gene-Replacement Therapy (GRT) for Spinal Muscular Atrophy Type II (SMA2) (STRONG) R. Finkel, J. Day, B. Darras, N. Kuntz, A. Connolly, T. Crawford, R. Butterfield, P. Shieh, G. Tennekoon, S. Iannaccone, M. Meriggiolo, S. Spector, F. Ogrinc, J. L’Italien, C. Wells, B. Kaspar, D. Sproule, D. Feltner, J. Mendell
11:30 a.m.–6:30 p.m. P1.8-001 The Impact of Ethnicity on the Phenotype of a Monogenetic Disorder: Sinocerebellar Ataxias Type III S. Gan, K. Figueroa, S. Perlman, G. Wilmot, C. Gomez, J. Schmahmann, H. Paulson, V. Shakkottai, S. Ying, T. Zesiewicz, K. Bushara, M. Geschwind, G. Xia, SH. Subramony, T. Ashizawa, S. Pulst, N. Wang, S. Kuo

Monday, May 6

Time Topic Presenter
11:30 a.m.–6:30 p.m. P2.2-036 GAD65 and Glycine Receptor-Associated Neurologic Autoimmunity and Stiff-Person Syndrome within the University of Utah Health Care System J. Galli, A. Piquet, J. Kresser, J. Klein, J. Warner, K. Digre, L. Peterson, A. Tebo, T. Haven, M. Paz Soldan, J. Rose, J. Greenlee, S. Clardy
11:30 a.m.–6:30 p.m. P2.4-012 The Prevalence, Severity, and Risk Factors for Chemotherapy Induced Peripheral Neuropathy and 0 and 2 Years After the Completion of Paclitaxel Therapy N. Kolb, S. Karafiath, F. Vivanco, J. Singleton, A. Smith
11:30 a.m.–6:30 p.m. P2.9-061 ENIGMA Military Brain Injury: Altered Subcortical Volume in Chronic TBI Revealed by Mega-Analysis E. Dennis, E. Wilde, A. Zavaliangos-Petropulu, M. Newsome, R. Scheibel, M. Troyanskaya, C. Velez, B. Wade, A. Drennon, G. York, E. Bigler, T. Abildskov, B. Taylor, C. Jaramillo, B. Eapen, H. Belanger, R. Morey, C. Haswell, H. Bouchard, M. Adamson, X. Kang, I. Koerte, M. Shenton, H. Levin, S. Hinds, W. Walker, P. Thompson, D. Tate

Tuesday, May 7

Time Topic Presenter
11:30 a.m.–6:30 p.m. P3.1-009 Frontotemporal Lobar Degeneration in the Differential Diagnosis of the Oldest-Old L. Embree, J. Sonnen, J. Hoffman, Y. Anzai, D. Hammers, A. Kucera, N. Foster
11:30 a.m.–6:30 p.m. P3.6-055 Multi-sensory gain abnormalities in postural tachycardia syndrome exceed those of migraine L. Millsap, K. Brennan, M. Cortez
11:30 a.m.–6:30 p.m. P3.8-040 Estimating and Individual’s Rise of Parkinson’s Disease Based on Comprehensive Family History P. Moretti, S. Pulst, L. Cannon-Albright
11:30 a.m.–6:30 p.m. P3.10-023 The Effect of Lacosamide on Chronic Migraine: Retrospective Analysis in a Single Center Healthcare Academic Institute H. Yuan, K. Wong, R. Davis, S. Ozudogru

Wednesday, May 8

Time Topic Presenter
11:30 a.m.–6:30 p.m. P4.2-013 Dimethyl Fumarate Dose Reduction in Lymphopenic Relapsing Remitting Multiple Sclerosis Patients: Clinical and MRI Outcomes K. Wong, R. Bacharach, E. Marini, T. Nguyen, S. Clardy, M. Cortez, L. DeWitt, J. Greenlee, J. Klein, M. Paz Soldan, J. Steffens, J. Rose
11:30 a.m.–6:30 p.m. P4.2-017 Among Real-World Multiple Sclerosis Patients that Experience Delayed-Release Dimethyl Fumarate-Associated Lymphopenia, Meaningful Lymphocyte Reconstitution Occurs Approximately 3 Months After Discontinuation of Delayed-Release Dimethyl Fumarate J. Rose, E. Alvarez, D. Okuda, M. Gudesblatt, E. Riser, T. Spelman, H. Butzkueven, S. Fam, K. Riester, F. Wu, C. Miller
11:30 a.m.–6:30 p.m. P4.4-005 Two Cases of Spinal Muscular Atrophy due to Mutations in the VRK1 Gene A. Sung, P. Moretti, A. Shaibani
11:30 a.m.–6:30 p.m. P4.8-028 Tremor in the Degenerative Cerebellum: Towards the Understanding of Brain Circuitry for Tremor S. Kuo, R. Lai, D. Tomishon, K. Figueroa, S. Pulst, S. Perlman, G. Wilmot, C. Bomez, J. Schmahmann, H. Paulson, V. Shakkottai, S. Ying, T. Zesiewicz, K. Bushara, M. Geschwind, G. Xia, SH. Subramony, T. Ashizawa
11:30 a.m.–6:30 p.m. P4.9-023 A Quality Improvement Project Studying the Integration of a Proposed Diagnostic Algorithm on Inpatient Encephalitis into the Electronic Medical Record and its Impact on Length of Hospital Stay T. Kaplan, J. Kresser, J. Galli, T. Cho, S. Clardy, A. Piquet

Thursday, May 9

Time Topic Position
11:30 a.m.–6:30 p.m. P5.3-004 Sympathetic Nervous System Dysfunction Correlates with Increased Blood Pressure Variability after Acute Stroke A. de Havenon, K. Wong, M. Dela Cruz, M. Cortez, G. Hawryluk
11:30 a.m.–6:30 p.m. P5.3-055 Focal Parietal Lobe Atrophy in Antiphospholipid Syndrome: Retrospective Analysis K. Wong, W. Fang, E. Skalabrin, A. Sawitzke, E. Zamrini, K. Salzman, G. Stoddard, C. Davidson, J. Anderson, J. Majersik
11:30 a.m.–6:30 p.m. P5.9-062 Regional Variation in Medicare Part D Drug Spending Amongst Neurologists A. de Havenon, K. Wong, B. Callaghan, G. Esper